Immune activation and depression in the elderly
Besides the monoamine hypothesis, the stress hypothesis and the vascular hypothesis, the inflammatory hypothesis might be an etiological explanation for late-life depression. There is a growing amount of evidence to support this hypothesis. In animal studies, injection with cytokines was shown to cause behavioural changes ('sickness behaviour') similar to depressive symptoms in humans. Cytokine treatment of certain tumours and chronic hepatitis can also cause depressive symptoms. The prevalence of depression in patients with autoimmune diseases is higher than in the general population. Etanercept had a favourable effect on the depressive symptoms in patients with psoriasis, independent of improvement of physical symptoms. Cytokines affect the hypothalamus-pituitary-adrenal axis and cerebral neurotransmitter systems, both of which are thought to be involved in depression. Immune activation has been associated with depression, and several anti-depressive treatments affect immune parameters, although inconsistently. Since the aging process is associated with a dysregulation of the immune system, the inflammation hypothesis might be particularly true in late-life depression.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2008 |
---|---|
Erschienen: |
2008 |
Enthalten in: |
Zur Gesamtaufnahme - volume:152 |
---|---|
Enthalten in: |
Nederlands tijdschrift voor geneeskunde - 152(2008), 25 vom: 21. Juni, Seite 1413-7 |
Sprache: |
Niederländisch |
---|
Weiterer Titel: |
Immuunactivatie en depressie bij ouderen |
---|
Beteiligte Personen: |
Maas, D W [VerfasserIn] |
---|
Themen: |
Antidepressive Agents |
---|
Anmerkungen: |
Date Completed 05.08.2008 Date Revised 15.07.2008 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM180874950 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM180874950 | ||
003 | DE-627 | ||
005 | 20231223160236.0 | ||
007 | tu | ||
008 | 231223s2008 xx ||||| 00| ||dut c | ||
028 | 5 | 2 | |a pubmed24n0603.xml |
035 | |a (DE-627)NLM180874950 | ||
035 | |a (NLM)18624003 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a dut | ||
100 | 1 | |a Maas, D W |e verfasserin |4 aut | |
245 | 1 | 0 | |a Immune activation and depression in the elderly |
246 | 3 | 3 | |a Immuunactivatie en depressie bij ouderen |
264 | 1 | |c 2008 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 05.08.2008 | ||
500 | |a Date Revised 15.07.2008 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Besides the monoamine hypothesis, the stress hypothesis and the vascular hypothesis, the inflammatory hypothesis might be an etiological explanation for late-life depression. There is a growing amount of evidence to support this hypothesis. In animal studies, injection with cytokines was shown to cause behavioural changes ('sickness behaviour') similar to depressive symptoms in humans. Cytokine treatment of certain tumours and chronic hepatitis can also cause depressive symptoms. The prevalence of depression in patients with autoimmune diseases is higher than in the general population. Etanercept had a favourable effect on the depressive symptoms in patients with psoriasis, independent of improvement of physical symptoms. Cytokines affect the hypothalamus-pituitary-adrenal axis and cerebral neurotransmitter systems, both of which are thought to be involved in depression. Immune activation has been associated with depression, and several anti-depressive treatments affect immune parameters, although inconsistently. Since the aging process is associated with a dysregulation of the immune system, the inflammation hypothesis might be particularly true in late-life depression | ||
650 | 4 | |a English Abstract | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 7 | |a Antidepressive Agents |2 NLM | |
650 | 7 | |a Cytokines |2 NLM | |
700 | 1 | |a Westendorp, R G J |e verfasserin |4 aut | |
700 | 1 | |a van der Mast, R C |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Nederlands tijdschrift voor geneeskunde |d 1946 |g 152(2008), 25 vom: 21. Juni, Seite 1413-7 |w (DE-627)NLM000034231 |x 1876-8784 |7 nnns |
773 | 1 | 8 | |g volume:152 |g year:2008 |g number:25 |g day:21 |g month:06 |g pages:1413-7 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 152 |j 2008 |e 25 |b 21 |c 06 |h 1413-7 |